Pay in 4 interest-free payments of $35.70 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
a Novel Antitumor Antibiotic Produced by a Nocardioides Sp
GNE-6776 selectively inhibits recombinant USP7 relative to 36 other deubiquitinases
4SC-202 has very high selectivity over ClassIIa/IIb/III HDACs
is a new oxazolidinone with cyclic amidrazone
InChi: InChI=1S/C19H20ClNO4/c1-19(2
PR-104A - CAS# 680199-06-8 )2-Boc a Novel Antitumor Antibiotic ProducedPR 104A (SN 27858) is the alcohol metabolite of phosphate prodrug PR 104. PR 104A is a hypoxia selective DNA cross linking agent DNA damaging agent and cytotoxin. Antitumor Activity. PR 104A is metabolized under hypoxia by the 1 electron NADPH: cytochrome P450 oxidoreductase. PR 104A can be used for the research of relapsed refractory T lineage acute lymphoblastic leukemia (T ALL). Product information CAS Number: 680199 06 8 Molecular Weight: 499. 29
US$ 45.00
US$ 165.00
US$ 1495.00
US$ 145.00
US$ 17.00
US$ 64.00
US$ 30.00
US$ 275.00
US$ 150.00
US$ 108.00